Hematological Malignancies Program Members

  • Doralina Anghelescu, MD

    Department of Anesthesiology
    Research interests: pain management, anesthesia risks, palliative care

  • Cheng Cheng, PhD

    Department of Biostatistics
    Research interests: statistical methods in cancer genomics and genetics

  • John K. Choi, MD, PhD

    Department of Pathology
    Research interest: To understand the mechanisms by which the transcription factor E2A regulate normal and leukemic precursor B cell proliferations

  • Lea C. Cunningham, MD

    Department of Bone Marrow Transplantation & Cellular Therapy
    Research interests: development of novel immunomodulatory therapies

  • James R. Downing, MD

    St. Jude President and Chief Executive Officer
    Department of Pathology
    Research interests: the molecular pathology of acute leukemia

  • William E. Evans, PharmD

    Department of Pharmaceutical Sciences
    Research interests: pharmacogenomics of antileukemic agents in children

  • Tanja Gruber, MD, PhD

    Department of Oncology
    Research interests: molecular pathology of infantile leukemia

  • Hiroto Inaba, MD, PhD

    Department of Oncology
    Research Interests: novel therapies for leukemia/lymphoma, especially acute myeloid leukemia and lymphoblastic lymphoma

  • Sima Jeha, MD

    Department of Oncology
    Research interests: childhood leukemias, developmental therapeutics

  • Jeffery M. Klco, MD, PhD

    Department of Pathology
    Research interests: Genomic and functional characterization of acute myeloid leukemia

  • Mondira Kundu, MD, PhD

    Department of Pathology
    Research Interests: Mechanisms involved in mitochondrial clearance and links to hematopoietic malignancies

  • Monika Metzger, MD

    Department of Oncology
    Research interests: Hodgkin and non-Hodgkin lymphomas, leukemias, IOP

  • Charles G. Mullighan, MBBS (Hons), MSc, MD

    Co-Leader, Hematologic Malignancies Program
    Department of Pathology
    Research interests: genomic profiling of acute leukemia

  • Stan Pounds, PhD

    Department of Biostatistics
    Research interests: develop statistical methods for genomics studies

  • Ching-Hon Pui, MD

    Co-Leader, Hematologic Malignancies Program
    Department of Oncology
    Research interests: biology and treatment of childhood leukemia

  • Mary V. Relling, PharmD

    Department of Pharmaceutical Sciences
    Research interests: pharmacokinetics and genetics of leukemia therapy

  • Raul C. Ribeiro, MD

    Department of Oncology
    Research interests: hematological malignancies

  • Jeffrey E. Rubnitz, MD, PhD

    Department of Oncology
    Research interests: treatment of acute myeloid leukemia

  • John T. Sandlund, MD

    Department of Oncology
    Research interests: clinical and biologic investigation of NHL and ALL

  • Erin G. Schuetz, PhD

    Department of Pharmaceutical Sciences
    Research interests: mechanisms of human variation in drug response

  • John D. Schuetz, PhD

    Department of Pharmaceutical Sciences
    Research interests: regulation and function of ABC transporters

  • Ashok Srinivasan, MD

    Department of Bone Marrow Transplant & Cellular Therapy
    Research interests: infections in the immune-compromised host

  • Brandon Triplett, MD

    Department of Bone Marrow Transplantation & Cellular Therapy
    Research interests: Hematopoietic cell transplant for high risk leukemia; Use of alternative donors in patients lacking a fully matched sibling donor; Immune reconstitution following hematopoietic cell transplant

  • Mitchell Weiss, MD, PhD

    Department of Hematology
    Research interests: blood development and associated diseases

  • Jun J. Yang, PhD

    Department of Pharmaceutical Sciences
    Research interests: the genomics of hematologic tumors, with particular interests in genomic characterization of inter-patient variability in anti-leukemia drug response and disease susceptibility